Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL network phase II trial

Item Type:	Letter
Title:	Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL network phase II trial
Creators Name:	Ferrero, S. and Pastore, A. and Scholz, C.W. and Forstpointner, R. and Pezzutto, A. and Bergmann, L. and Truemper, L. and Finke, J. and Keller, U. and Ghione, P. and Passera, R. and Hiddemann, W. and Weigert, O. and Unterhalt, M. and Dreyling, M.
Keywords:	Europe, Follow-Up Studies, Local Neoplasm Recurrence, Mantle-Cell Lymphoma, Monoclonal Antibodies, Neoplasm Drug Resistance, Neoplasm Staging, Prognosis, Prospective Studies, Radioimmunotherapy, Survival Rate, Yttrium Radioisotopes
Source:	Leukemia
ISSN:	0887-6924
Publisher:	Nature Publishing Group
Volume:	30
Number:	4
Page Range:	984-987
Date:	April 2016
Official Publication:	https://doi.org/10.1038/leu.2015.215
PubMed:	View item in PubMed

Repository Staff Only: item control page